Kazia Therapeutics Limited. Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019
Kazia Therapeutics Limited. (KZIA) reported Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019 of 1.07 AUD/shares for the 12-month period ending 2025-06-30, per its 20-F filed 2025-11-07.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019 · last filed 2025-11-07
| Period end | Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019 12 month | Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019 12 month as first filed |
|---|---|---|
| 2025-06-30 | 1.07 AUD/shares 20-F · filed 2025-11-07 | |
| 2024-06-30 | 0.43 AUD/shares 20-F · filed 2025-11-07 | 0.43 AUD/shares 20-F · filed 2024-11-15 |
| 2023-06-30 | 1.90 AUD/shares 20-F · filed 2024-11-15 | |
| 2022-06-30 | 1.11 AUD/shares 20-F · filed 2023-10-26 | |
| 2021-06-30 | 1.85 AUD/shares 20-F · filed 2022-10-17 | 1.85 AUD/shares 20-F · filed 2021-10-07 |
| 2020-06-30 | 3.72 AUD/shares 20-F · filed 2021-10-07 |